Category : Search result: Evangeline Lilly concussion


Rugby to trial lower tackle height over concussion concerns

World Rugby announces a trial to lower the legal tackle height at the elite level starting in 2025, a major move aimed at reducing head injuries and concussions in the sport. Learn about the new rules and their potential impact.

Eli Lilly cuts price of obesity drug Zepbound

Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.

Eli Lilly Reaches $1 Trillion Valuation Milestone

Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.

Trump Obesity Drug Deal Boosts Pharma Stocks

Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.

Page 1 of 1